Real-time enrollment status for this macular degeneration clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 7:19 AM UTC
| NCT Number | NCT06550011 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Macular Degeneration |
| Phase | Clinical Trial |
| Target Enrollment | 18 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Avirmax Biopharma Inc |
| Last Updated on CT.gov | February 12, 2026 (2 weeks ago) |
As of March 2, 2026: Clinical trial NCT06550011 is currently active_not_recruiting participants. This clinical trial study for macular degeneration is not currently accepting new participants at 4 locations across the United States. The study is sponsored by Avirmax Biopharma Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06550011 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06550011 was last updated 2 weeks ago (February 12, 2026). HelloStudys verifies this status automatically.